<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
  <akn:act name="dc-code">
    <akn:meta>
      <akn:identification source="#cosilico">
        <akn:FRBRWork>
          <akn:FRBRuri value="/akn/us-dc/code/1-620.35"/>
          <akn:FRBRdate date="2025-12-31" name="retrieval"/>
          <akn:FRBRauthor href="#dc-council"/>
          <akn:FRBRcountry value="us-dc"/>
        </akn:FRBRWork>
        <akn:FRBRExpression>
          <akn:FRBRuri value="/akn/us-dc/code/1-620.35/eng@2025"/>
          <akn:FRBRdate date="2025-12-31"/>
          <akn:FRBRauthor href="#cosilico"/>
          <akn:FRBRlanguage language="en"/>
        </akn:FRBRExpression>
      </akn:identification>
    </akn:meta>
    <akn:body>
      <akn:section eId="sec_1_620_35">
        <akn:num>1-620.35</akn:num>
        <akn:heading>Procedure and employee impact.</akn:heading>
<akn:subsection eId="subsec_1-620_35_a">
      <akn:num>(a)</akn:num>
      <akn:content><akn:p>A drug and alcohol testing policy, including the notice required by § 1-620.32(d), shall be issued at least 30 days in advance of implementing the drug and alcohol program to inform District employees of the requirements of the program and to allow each employee one opportunity to seek treatment, if he or she has a drug or alcohol problem. Thereafter, any confirmed positive drug test results, positive breathalyser test, or a refusal to submit to a drug test or breathalyser shall be grounds for termination of employment in accordance with this chapter.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_1-620_35_b">
      <akn:num>(b)</akn:num>
      <akn:content><akn:p>The testing program shall be implemented as a single program.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_1-620_35_c">
      <akn:num>(c)</akn:num>
      <akn:content><akn:p>The results of a random test conducted pursuant to this subchapter shall not be turned over to any law enforcement agency without the employee’s written consent.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_1-620_35_d">
      <akn:num>(d)</akn:num>
      <akn:content><akn:p>An applicant may be offered employment contingent upon receipt of a satisfactory drug testing result, and may begin working in a position that is not a safety-sensitive position prior to receiving the results.</akn:p></akn:content>
    </akn:subsection>
      </akn:section>
    </akn:body>
  </akn:act>
</akn:akomaNtoso>
